A | B, C, D | E, F, G | H, I, J | K, L, M | N | O, P, Q | R, S, T | U, V, W, X, Y, Z


- B, C, D -

 Bayer Corporation

With focus on natural science, technology, and medicine, the Bayer Science and Education Foundation supports those with dedication and claim outstanding achievements in their field. A variety of science awards are available honoring notable research in innovative areas such as chemistry, biochemistry, and medicine. The Foundation rewards scientific excellence with the aim to raise acceptance for technology in a broader public and to make science more popular.

Awards include:

  • Otto Bayer Award - Awarded to researchers who have made pioneering contributions in chemistry and biochemistry.
  • Hanson Family Award - For outstanding research work related to medical science and medicine.
  • Bayer Early Excellence in Science Award
  • Bayer Thrombosis Research Award
More information
 Brain and Behavior Research Foundation

Formerly known as the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Brain and Behavior Research Foundation has awarded nearly $300 million in over 4,000 NARSAD grants to more than 3,000 scientists around the world since 1987.

The Foundation is committed to alleviating the suffering caused by mental illness by awarding grants leading to advances and breakthroughs in scientific research. One hundred percent of donor contributions for research are invested in NARSAD grants leading to discoveries in understanding causes and improving treatments of disorders such as depression, bipolar disorder, schizophrenia, autism, attention-deficit hyperactivity disorder, and anxiety disorders such as obsessive-compulsive and post-traumatic stress disorders.

Funding is focused on four priority areas to better understand and treat mental illness: basic research, new technologies, diagnostic tools/early intervention, and next generation therapies.

Awards offered include:

  • NARSAD Young Investigator Grant - Supports scientists at the advanced postdoctoral or assistant professor (or equivalent) level. Grants are up to $30,000 per year for one or two years.
  • NARSAD Independent Investigator Grant - Supports scientists at the associate professor (or equivalent) level. Grants are up to $100,000 over a two-year period.
  • NARSAD Distinguished Investigator Grant - Supports scientists at the full professor level (or equivalent) level. Grants are up to $100,000 for one year.
More information
 Bristol-Myers Squibb

With a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, Bristol-Meyers Squibb considers requests for clinical research trials from all clinical and therapeutic areas, and gives priority to proposals that support medical plans in cardiovascular/metabolics, neuroscience, cancer, immunology, and virology.

Bristol-Meyers Squibb's investigator-sponsored research includes Clinical Research, Non-Interventional Research, Non-Clinical Research, Pediatric Clinical Research, and Immunoscience, Virology, and Oncology MD Research Program.

The Immunoscience, Virology, and Oncology MD Research Program supports studies furthering the science and knowledge of Rheumatology, HIV/AIDS, HBV, and Oncology. Up to $20,000 is awarded for Immunoscience and Oncology fellows, up to $30,000 for Virology fellows, each supporting research-related expenses for a one-year research period.

 Burroughs Wellcome Fund (BWF)

An independent private foundation dedicated to advancing the biomedical sciences through supporting research and other scientific activities has two primary goals: to help scientists early in their careers develop as independent investigators and to advance fields in the basic biomedical sciences that are undervalued or in need of particular encouragement.

BWF encourages applications from physician-scientists, women, and under-represented minorities. Most awards are made to degree-granting institutions on behalf of individual researchers nominated by their institution.

Grants awarded by BWF include:

  • Career Award for Medical Scientists - A five-year, $700,000 award for physician-scientists to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research.
  • Under-Represented Minority Post-Doctoral Enrichment Program - Awards $50,000 over three years to support career development activities for under-represented minorities postdoctoral fellows whose research is already supported and whose training and professional development are guided by mentors committed to helping them advance in careers in biomedical or medical research.
More information
 Cancer Research Institute

Conquering cancer through expanded research, applied knowledge, coordinated partnerships, and community commitment is the focus of the Cancer Research Institute. Founded in 1953, $200 million has been provided to nearly 3,000 scientists who have used the funding to conduct laboratory studies, build research teams, and launch clinical trials. Support is offered for scientists at any stage of their career and levels of scientific inquiry, from basic research to coordinated clinical trials.

Awards available include the Cancer Research Institute-Irvington Institute Fellowship Program, established in 1971, is the longest-standing continuous program to support and train young immunologists. The program has awarded 1,227 fellows, two who went on to win the Nobel Prize.

Fellowship appointments are for three years: $50,000 for the first year, $53,000 for the second year, and $57,000 for the third year. Deadlines for applications are April 1 and October 1 annually.

More information
 Centers for Disease Control (CDC)

The CDC awards nearly 85% of its budget through grants and contracts to help further its mission to promote health and quality of life be preventing and controlling disease, injury, and disability.

Each year the CDC awards approximately $7 billion in over 14,000 separate grant and contract actions. The CDC utilizes grants to assist other health-related and research organizations that contribute to their mission of health promotion through health information dissemination, preparedness, prevention, research, and surveillance.

More information
 Civilian Research & Development Foundation (CRDF)

The CRDF is an independent, nonprofit organization promoting international scientific and technical collaboration through grants, technical resources, training, and services. The mission of the CRDF is to promote the application of science and technology to economic growth through partnerships and training that foster invention, innovation, entrepreneurship, and commercialization of technology, and to strengthen university research and education in science and engineering.

Current funding opportunities include:

  • Chemical Safety and Security Trainings - On behalf of the US Department of State's Chemical Security Engagement Program to implement local chemical security and safety trainings in academic and industrial settings. These trainings build awareness of the chemical threat and encourage trainees to implement practices for safe and secure chemicals management in their labs and facilities. Deadline for application is January 31, 2013.
  • Chemical Security Improvement Grants - Improving the physical and procedural security of chemical laboratories and facilities, these grants contribute to the safety and security of industrial and academic chemical facilities, including employees and their communities, and aim to prevent the accidental or intentional misuse of chemicals. One-time awards range from $2,000 to $30,000, with applications accepted on a quarterly basis. Deadline for application is March 1, 2013.
More information
 Congressionally Directed Medical Research Programs (CDMRP)

The CDMRP is funded through the Department of Defense via annual Congressional legislation known as the Defense Appropriations Act. Funds are added every year during the budget approval cycle by members of the House or Senate in response to requests by consumer advocates and disease survivors.

The CDMRP manages Congressional Special Interest Medical Research Programs (CSI) encompassing breast, prostate, and ovarian cancers, neurofibromatosis, military health, and other specified areas. Since fiscal year 1992, the CDMRP has managed approximately over $6.5 billion in Congressional appropriations for peer-reviewed research aimed to prevent, control, and cure disease. Through fiscal year 2010, approximately 10,719 awards have been made to advance health care solutions via extramural grants, contracts, and cooperative agreements.

  • Breast Cancer Research Program (BCRP) - Established in FY92 to support innovative research focused on ending breast cancer, the BCRP seeks to accelerate high-impact research, encourage innovation, and stimulate creativity. The BCRP also seeks to bring new investigators into the breast cancer field, and to facilitate multidisciplinary collaborations. Funds appropriated for the BCRP through FY11 totaled over $2.6 billion.
  • Chronic Myelogenous Leukemia Research Program (CMLRP) - Supports research leading to the improvement of understanding, diagnosis, and treatment of CML and enhancing the quality of life of people with the disease. Awards are given according to a two-tier review process that includes peer and programmatic reviews, ensuring merit and attainment of program goals. CMLRP has supported awards in four mechanisms: Investigator-Initiated Research, Hypothesis Development, New Investigator, and Therapeutic Development Awards.
  • National Defense Science and Engineering Graduate Fellowship - Awarded to US citizens and nationals who intend to pursue a doctoral degree in one of 15 disciplines including biosciences, chemistry, and cognitive, neural, and behavioral sciences. Fellowships are for three years and pay full tuition and fees, a monthly stipend, and up to $1,000 a year in medical insurance.
  • Neurofibromatosis Research Program (NFRP) - With funds allocated through FY11 totaling $230.1 million, the NFRP supports high-impact research of exceptional scientific merit promoting the understanding, diagnosis, and treatment of NF, including Type 1, Type 2, and Schwannomatosis. The NFRP seeks to support research in neglected areas of NF, as well as fostering the next generation of investigators, and supporting multidisciplinary collaborations that would bring new perspectives to the field.
  • Ovarian Cancer Research Program (OCRP) - The OCRP offers five awards all with the vision of eliminating ovarian cancer: Outcomes Consortium Development Award, Ovarian Cancer Academy Award, Pilot Award, Synergistic Translational Leverage Award, and Teal Innovator Award. For FY12, $16 million in funds were allocated for innovative, high-impact research.
  • Prostate Cancer Research Program (PCRP) - Established in 1997, the PCRP promotes innovative research focused on eradicating prostate cancer. Funds totaling $1.13 billion were allocated for FY91-FY11, and the PCRP seeks to promote highly innovative research. The PCRP also seeks high-impact research with near-term clinical relevance, multidisciplinary synergistic research, and research on disparities in the incidence and mortality of prostate cancer.
  • Tuberous Sclerosis Complex Research Program (TSCRP) - The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis of TSC and to translate these findings into a cure. The TSCRP encourages applications that address such vital areas as genetic, epigenetic, and non-genetic modifiers of TSC, the impact of TSC manifestations over the lifespan, and strategies for the treatment and prevention of TSC.
 Cystic Fibrosis Foundation

When the Cystic Fibrosis Foundation was founded in 1955, children with the disease rarely lived long enough to attend elementary school. With the Foundation's investment in research and comprehensive care, many people with cystic fibrosis can be expected to live into their 30s and beyond.

The Foundation funds more cystic fibrosis research than any other organization, supporting the development of new drugs, improving the quality of life for those with cystic fibrosis, and finding a cure. The Foundation funds and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease.

In 1989, Cystic Fibrosis Foundation-supported researchers discovered the defective gene that causes cystic fibrosis, and the Foundation also played an integral role in the development and FDA approval of four therapies that are now a routine part of treatment regiments.

The Foundation supports nearly 30 potential new treatments for cystic fibrosis that are currently in development

More information
 Dermatology Foundation

The Dermatology Foundation Research Awards Program offers career development awards, fellowships, and grants that are intended for early academic careers and research efforts of physicians and scientists in dermatology and cutaneous biology. The Foundation provides research support that helps develop and retain tomorrow's teachers and researchers in dermatology, enabling advancement in patient care.

The annual Dermatology Foundation award offering has 13 funding categories supporting all aspects of dermatology, including a new career development award in dermatopathology. A survey conducted by the Foundation revealed that 80 percent of awardees have remained in academics and 86 percent of these individuals received federal funding, and each dollar of career development award funding garnered $10 or more in NIH grant support.

More information
 Doris Duke Charitable Foundation (DDCF)

The mission of the DDCF is to improve the quality of people's lives through grants supporting the performing arts, environmental conservation, medical research, and the prevention of child abuse. Since 1997, the DDCF has awarded grants totaling more than $1 billion. The Medical Research Program looks to support the prevention, treatment, and cure of human disease.

Awards offered include:

  • Clinical Scientist Development Award - Provides grants to junior physician-scientists to facilitate the transition to independent research careers. Applicants must hold an MD or foreign equivalent, Have a valid, active US medical license (but do not have to be a US citizen), and have a full-time faculty position no higher than assistant professor level. Since beginning in 1998, the DDCF has awarded 202 grantees totaling $90 million.
  • Distinguished Clinical Scientist Award - Recognizes outstanding mid-career physician-scientists to help bridge the gap between bench science and clinical research. From 1999-2008, five-year grants of $1.5 million were awarded to 40 mid-career scientists totaling more than $65 million.
  • Innovations in Clinical Research Award - Provides funding for early-stage research projects in clinical investigation to foster innovations in clinical research. In 2011, nine three-year grants of $486,000 were awarded to researchers conducting research that has the potential to accelerate innovative breakthroughs in sickle cell disease.
  • In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or tissue derived from animals will not be supported.
More information

A | B, C, D | E, F, G | H, I, J | K, L, M | N | O, P, Q | R, S, T | U, V, W, X, Y, Z